Safety of bevacizumab in patients younger than 4 years of age

VEGF is required for growth and survival in neonatal mice

Hans‐Peter Gerber, Kenneth J. Hillan, Anne Ryan et al. · Development · 1999 · 918 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study

Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint et al. · Neuro-Oncology · 2013 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

Ashwatha Narayana, Deborah Gruber, Saroj Kunnakkat et al. · Journal of neurosurgery · 2011 · 118 citations

Medicine, Oncology, Pharmacotherapy +17

Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab

Robert A. Avery, Eugene Hwang, Regina I. Jakacki et al. · JAMA Ophthalmology · 2013 · 115 citations

Medicine, Oncology, Ophthalmology +17

How Vascular Endothelial Growth Factor-A (VEGF) Regulates Differentiation of Mesenchymal Stem Cells

Agnes D. Berendsen, Bjørn R. Olsen · Journal of Histochemistry & Cytochemistry · 2013 · 95 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17